Skip to content

Yoga for Premenstrual syndrome

Integral yoga protocol for managing Premenstrual syndrome: A Randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087946
Enrollment
100
Registered
2025-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

None listed

Sponsors

University of Patanjali
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study will include females between the ages of 18 and 40 who experience premenstrual syndrome (PMS). Eligible participants must have a regular menstrual cycle, ensuring the consistency needed to accurately assess the impact of PMS. Additionally, participants must be willing to provide informed consent and actively participate in the study.

Exclusion criteria

Exclusion criteria: The study will exclude females of reproductive age who have chronic infectious diseases, mental health issues, or any addictive behaviors such as smoking, alcoholism, or drug addiction. Additionally, individuals who have undergone recent surgery or are currently pregnant will not be eligible for participation. Those who express a disinterest in yoga or are already engaged in regular yoga practice, along with those who consistently participate in other forms of exercise, will also be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Primary outcomes: The severity of symptoms of PMS including depression, anxiety and stress measured by DASS questionnaire, (2) fatigue measured by fatigue severity scale, (3) mood swings measured by the brief mood introspection scale, (4) quality of life or well-being measured by the premenstrual syndrome quality of life scale, including alterations in sleep patterns, cramps/pain (including headaches and abdominal, back, and lower back pain).Timepoint: At baseline (T0) and at 3 months (T1)

Secondary

MeasureTime frame
NILTimepoint:

Countries

India

Contacts

Public ContactKomal

Department of yogic science

yogidrrudra@gmail.com9634510540

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026